Company / Free Cash Flow
Entera Bio Ltd. Free Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$6.8M
FY2025
5-year range
-$12.5M / -$6.8M
FY2021-FY2025
Trend
+6.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$13M to -$7M over the past 2 years.
Based on SEC 10-K filings.
-$7M in FY2025.
Improved from -$13M to -$7M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 6.9% year-over-year.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.8M | +6.9% |
| FY2024 | -$7.3M | +41.6% |
| FY2023 | -$12.5M | -38.2% |
| FY2022 | -$9.1M | +14.4% |
| FY2021 | -$10.6M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026